Montross Franklin IV
Known title: DirectorCIK: 0001848574
Associated companies
Transaction History
| SPNT | ▲ Buy | Grant | 7,456 | $137K | 5/27/2025 | View on chart |
| SPNT | ▲ Buy | Grant | 10,528 | $137K | 5/21/2024 | View on chart |
| SPNT | ▲ Buy | Grant | 14,929 | $137K | 6/15/2023 | View on chart |
| SPNT | ▲ Buy | Grant | 23,424 | $0 | 5/19/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise
Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.
SiriusPoint (SPNT) Valuation Questioned After Recent Price Rise. Recent market discussion has focused on whether SiriusPoint remains undervalued following a recent increase in its share price. The company currently trades with a low trailing P/E ratio of 5.7, which is significantly below the average analyst target of $28.75. This valuation gap has prompted investors to reassess the stock's position within its 52-week range of $17.39 to $26.50.